It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HYPR’s FA Score shows that 1 FA rating(s) are green whileTMCI’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HYPR’s TA Score shows that 2 TA indicator(s) are bullish while TMCI’s TA Score has 4 bullish TA indicator(s).
HYPR (@Medical Specialties) experienced а -8.32% price change this week, while TMCI (@Medical Specialties) price change was -8.28% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -5.77%. For the same industry, the average monthly price growth was -2.12%, and the average quarterly price growth was -0.29%.
HYPR is expected to report earnings on May 08, 2025.
TMCI is expected to report earnings on Aug 12, 2025.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
HYPR | TMCI | HYPR / TMCI | |
Capitalization | 70.8M | 806M | 9% |
EBITDA | -47.06M | -39.01M | 121% |
Gain YTD | -24.989 | 4.167 | -600% |
P/E Ratio | N/A | N/A | - |
Revenue | 11M | 187M | 6% |
Total Cash | 75.2M | 123M | 61% |
Total Debt | 185K | 70.3M | 0% |
HYPR | TMCI | |
---|---|---|
RSI ODDS (%) | N/A | 5 days ago83% |
Stochastic ODDS (%) | 5 days ago76% | 5 days ago74% |
Momentum ODDS (%) | 5 days ago66% | 5 days ago83% |
MACD ODDS (%) | 5 days ago73% | 5 days ago90% |
TrendWeek ODDS (%) | 5 days ago76% | 5 days ago86% |
TrendMonth ODDS (%) | 5 days ago78% | 5 days ago85% |
Advances ODDS (%) | 28 days ago72% | 16 days ago73% |
Declines ODDS (%) | 5 days ago79% | 5 days ago84% |
BollingerBands ODDS (%) | 5 days ago86% | 5 days ago76% |
Aroon ODDS (%) | 5 days ago81% | 5 days ago89% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MDCIX | 14.47 | -0.65 | -4.30% |
Madison Mid Cap I | |||
ADEIX | 14.79 | -0.82 | -5.25% |
Ancora Dividend Value Equity I | |||
EQPGX | 19.33 | -1.17 | -5.71% |
Fidelity Advisor Equity Growth I | |||
EPSPX | 20.70 | -1.26 | -5.74% |
NYLI Epoch Global Equity Yield Class A | |||
SUVAX | 10.57 | -0.68 | -6.04% |
PGIM Quant Solutions Large-Cap Val A |
A.I.dvisor indicates that over the last year, HYPR has been loosely correlated with SGHT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if HYPR jumps, then SGHT could also see price increases.
Ticker / NAME | Correlation To HYPR | 1D Price Change % | ||
---|---|---|---|---|
HYPR | 100% | -4.44% | ||
SGHT - HYPR | 33% Loosely correlated | +3.14% | ||
ICAD - HYPR | 29% Poorly correlated | -5.41% | ||
RSLS - HYPR | 29% Poorly correlated | +21.15% | ||
TMCI - HYPR | 28% Poorly correlated | -1.02% | ||
RBOT - HYPR | 25% Poorly correlated | -7.48% | ||
More |
A.I.dvisor indicates that over the last year, TMCI has been loosely correlated with INSP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TMCI jumps, then INSP could also see price increases.
Ticker / NAME | Correlation To TMCI | 1D Price Change % | ||
---|---|---|---|---|
TMCI | 100% | -1.02% | ||
INSP - TMCI | 54% Loosely correlated | -5.01% | ||
ATEC - TMCI | 42% Loosely correlated | N/A | ||
SMLR - TMCI | 39% Loosely correlated | -0.62% | ||
MASI - TMCI | 38% Loosely correlated | -5.23% | ||
FNA - TMCI | 35% Loosely correlated | -0.15% | ||
More |